Stock 6108 NEW RAY MEDICINE INTERNATIONAL HOLDING LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News New Ray Medicine International Holding Limited

Equities

6108

BMG647461117

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:08 27/06/2024 pm IST 		5-day change 1st Jan Change
0.043 HKD 0.00% Intraday chart for New Ray Medicine International Holding Limited -17.31% -14.00%
24/06 New Ray Medicine Shareholders to Vote July 16 on Purchase Contract MT
17/05 New Ray Medicine International Unit to Buy 16% Stake in Pharmaceutical Firm MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
New Ray Medicine Shareholders to Vote July 16 on Purchase Contract
MT
New Ray Medicine International Unit to Buy 16% Stake in Pharmaceutical Firm
MT
New Ray Medicine International Holding Limited entered into the Sale and Purchase Agreement to acquire 16% stake in China Nvwa Pharmaceutical Group Limited from U Man Iong for HKD 17.3 million.
CI
New Ray Medicine International Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
New Ray Medicine International Forecasts Decline in 2023 Loss
MT
New Ray Medicine International Holding Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
CI
New Ray Medicine International Holding Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
New Ray Medicine International Holding Limited Announces Company Secretary Changes
CI
New Ray Medicine International Holding Limited Appoints Zhou Wan as an Executive Director
CI
New Ray Medicine's 2022 Loss Balloons as Revenue Slumps 73%
MT
New Ray Medicine International Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
New Ray Medicine International Holding Limited Revises Earnings Guidance for the Fiscal Year 2022
CI
New Ray Medicine Expects Widening in Loss in 2022
MT
New Ray Medicine International Holding Limited Provides Unaudited Consolidated Guidance for the Year Ended December 31, 2022
CI
New Ray Medicine, Partners to Boost Registered Capital of Healthcare Industrial Park Construction Company
MT
New Ray Medicine Swings to H1 Loss
MT
New Ray Medicine International Holding Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
New Ray Medicine International Holding Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022
CI
New Ray Shareholders to Vote July 13 on $7 Million Sale of Stake in Medical Device Retailer
MT
New Ray Medicine International Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6108 Stock
  4. News New Ray Medicine International Holding Limited